OAFI presents results of three scientific studies at the World Congress of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

OAFI International Foundation has participated in the World Congress of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) that has taken place April 4 to 7 in Paris. The WCO-IOF-ESCEO is one of the largest and most prestigious international scientific meetings in the field of osteoporosis, osteoarthritis, fragility and sarcopenia. AOFI Foundation has presented the result of three scientific studies, carried out with the objective of continuing to obtain knowledge to advance the improvement of the quality of life of patients with osteoarthritis.

Two of the initiatives presented at the WCO-IOF-ESCEO – “Results of the global survey on the patient’s perception of osteoarthritis (GOAPPS)” and “Social and individual factors that can influence the quality of life of patients with knee osteoarthritis : a systematic review “- are the result of an international work team (OsteoArthritis Task Force) leaded by OAFI International Foundation and the Arthritis Foundation of the United States,. The task force includes members of the Pan American Association of Associations for Rheumatology (PANLAR) in North and South America and patients affiliated with the Italian Society of Rheumatology, as well as other global OA experts.

These two works performed with the international team have been used to compile the overall perception of how OA impacts the lives of patients. The objectives are to evaluate the routes of administration of current global OA and improve the quality of life of patients through more efficient management and the definition of coherent evidence-based messages for the entire medical care team.

The third study presented at the WCO-IOF-ESCEO -“Expert consensus on the proper oral use of SYSADOA for the treatment of patients with osteoarthritis in primary care: Delphi study”- has been led by the OAFI Foundation so that the staff Primary care healthcare can make a more correct use of these drugs.

The initial results of these studies will continue to be presented at the next conferences and at the III International Congress of Patients with Arthrosis that will be held on October 3.4 and 5 in Barcelona.